Intelligent Prior Authorization, U.S. Healthcare Organizations

Gartner's Market Guide for Intelligent Prior Authorization, U.S. Healthcare Organizations, published February 12, 2026, scores a market whose starting condition is a statistic: U.S. payers authorize an estimated 182 million prior authorizations annually, and only 26 percent of claim submissions are done electronically. Prior authorization is healthcare's most expensive fax machine, and the 2026 guide scores the market replacing it.

The fax-era process

Prior authorization is the step where a payer approves a treatment before it happens, and for decades it ran on paper: faxes, phone calls, manual reviews, and the clinician's time burned chasing a signature.

The process's costs are the market's founding facts. It is among the most administratively complex and labor-intensive processes in healthcare, a significant contributor to revenue leakage, and a documented driver of clinician burnout. The guide's own framing lists the incentives now pushing automation: clinician burnout, cost optimization, care access pressure, and regulation.

The automation cannot outrun the fax it was born to replace, but the 2026 edition is the first where the replacement looks inevitable.

The February 2026 Market Guide for Intelligent Prior Authorization, U.S. Healthcare Organizations, and its vendor field

The current edition published February 12, 2026, authored by Connie Salgy, Roger Benn, and Amanda Dall'Occhio, following Gartner's first guide for the market in late 2023.

The definition is specific: a U.S.-healthcare-specific solution that helps payers' and providers' IT and business teams deliver transparent, frictionless, and accurate prior authorizations to ensure timely care delivery, with APIs, natural language processing and AI tools, workflow automation, predictive processing, and consumer-centric experiences.

The confirmed representative vendors are Infinx, with its Patient Access Plus platform built around configurable work queues, guard-railed automation, human-in-the-loop coverage, and multiple integration options, HL7, API, FHIR, and payer portals, and ZeOmega, with its Smart Auth Optimizer applying AI and workflow automation to real-time data exchange between payers and providers.

The 182 million faxes

The volume statistic deserves the slow reading, because it defines the market's economics. 182 million authorizations a year, with 74 percent of submissions still not electronic, is a workload measured in human minutes and payer-provider friction at a scale few other healthcare processes match.

Each manual authorization is a delay for a patient, an administrative cost for both parties, and a denials risk for the provider. The electronic gap is the market's total addressable problem, and the guide's framing, a new, emerging market, is honest about how much of it remains unsolved.

Twenty six percent electronic is a market still running on paper, and the vendors are selling the conversion.

The agentic standard arriving

The guide's forward view is the agentic layer becoming standard: automated validation of prior authorization requests, identification of missing documentation, matching patient records against clinical guidelines, drafting supporting documentation, and continuous learning from outcomes.

Read that list as the market's automation ladder. The first rungs, validation and documentation checks, are the efficiency story. The higher rungs, guideline matching and continuous learning, are the clinical-judgment story, and they carry the governance questions: who signs the agent's determination, how is it explained, and where is the audit trail when a patient's care is delayed by a machine.

The agent that drafts the supporting documentation is the workflow, not a feature, and the vendors shipping it are the ones the guide's criteria are written around.

The data barrier underneath

The guide's caution is the market's honest core: many organizations still face foundational barriers around data access and data quality, with critical information scattered across legacy systems, PDFs, and faxes.

The agentic promise depends on the data layer it sits on, and the data layer is the industry's oldest problem. A vendor's AI cannot validate a request whose clinical context lives in an unscanned PDF, and the successful transformation, the guide says, requires both advanced technology and a modern, interoperable data architecture.

The mandates set the deadline, and the data quality sets the pace, and the buyers who skip the data work are buying the agent's marketing instead of its capability.

The regulatory clock

The regulatory layer is the market's demand engine, and the guide names it: CMS-0057 and the broader CMS interoperability and prior authorization rules, pushing transparency and API-enabled workflows.

The mandates convert the market's soft incentives into deadlines. The payer that must expose API endpoints, the provider that must receive electronic determinations, both become buyers of exactly the capabilities the guide scores. The regulatory clock is the reason the market's growth is compulsory rather than optional, and the vendors' compliance depth is the buying criterion the mandates created.

Four questions for the payer or provider buyer

Which side of the transaction is the purchase for? The guide scores one market with two buyers, payers and providers, and the requirements diverge. Name the side before the vendor does.

What is the human-in-the-loop boundary, exactly? The guard-railed automation is the market's trust model. Ask which determinations the agent makes alone, which it escalates, and how the audit trail reads to a regulator.

Does the integration cover the buyer's actual channels? The electronic gap is the work. Ask for the payer portal, FHIR, and legacy system integrations demonstrated against the buyer's real traffic, not the vendor's reference flows.

Is the data foundation in scope? The guide says the transformation needs the modern data architecture. Ask whether the vendor's engagement includes the data cleanup, or assumes it, because the assumption is where the project stalls.

Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

This pairs directly with Revenue Cycle Management Solutions. Gartner's guide for this healthcare finance category exists mostly as a purpose statement in the public record, but the adjacent prior-authorization data it draws on puts a number on the leak: 182 million annual authorizations, only a quarter processed electronically.

This market sits next to Customer Experience Platforms For Healthcare, covered separately on this site. Consumer comfort with a general AI chatbot and with their own health insurer's AI tool differ by two percentage points. That indifference is the strategic problem this category exists to address.